Answers are grounded in this paper and cite their sources.
The target compounds 4-(((1H-heteraryl)imino)methyl)-N,N-bis(4-(((4-((4-nitrophenyl) diazenyl)phenyl)imino)methyl)phenyl)aniline (7a-q) were prepared starting with 4,4′-diformyltriphenyl amine (2) which subjected to react with N-bromosuccinimide to give bromodiformyltriphenyl amine (4). Compound 4 reacted with two moles of 4-nitro-4′-aminoazobenzene to give the di-Schiff base 5. Compound 5 converted to its corresponding formyl derivative 6 by reaction with n-BuLi. The reaction of the formyl derivative 6 with seventeen amino heteraryl compounds afforded the target compounds 7a-q. All the newly prepared compounds were characterized by different spectroscopic and elemental analyses. Compounds 7a-q were screened for their antimicrobial activities against yeast-like fungi (C. albicans), Gram-negative (GN) bacteria (P. aeruginosa and E. coli), and Gram-positive (GP) bacteria (S. thuringiensis and B. subtilis). Compounds 7d, 7k, 7l, and 7q showed the highest activity against Gram-positive bacteria. The results of antimicrobial activity showed that it is highly affected by the used amine basicity.
No takes yet. Share an insight, caveat, or question.
Omar M. Alatawi (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: